Thumbnail
Access Restriction
Open

Author Yan, Yimin ♦ Yang, Xiaohong ♦ Zhao, Tao ♦ Zou, Yi ♦ Li, Rui ♦ Xu, Yancheng
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword APPLIED LIFE SCIENCES ♦ ACETYLSALICYLIC ACID ♦ BIOLOGICAL RECOVERY ♦ CITRATES ♦ DISEASES ♦ INHIBITION ♦ INSULIN ♦ MITOCHONDRIA ♦ PHOSPHORYLATION ♦ RECEPTORS ♦ RNA ♦ TRANSCRIPTION ♦ TRANSCRIPTION FACTORS
Abstract Mitochondrial dysfunction has been associated with insulin resistance and diabetes. Decreased mitochondrial density and mitochondrial copy numbers have been found in insulin-resistant individuals. Restoration of the number of mitochondria and normal mitochondrial function has become an important therapeutic target of diabetes. Salicylate, the main active ingredient in aspirin, has been in medicinal use since ancient times. Little information regarding the effects of salicylate on mitochondrial function has been reported. In this study, we assessed the effects of salicylate on the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) signaling pathway and mitochondrial biogenesis in pre-adipocytes. Our findings demonstrate that treatment with salicylate promoted the expression of PGC-1α and its downstream targets nuclear respiratory factor 1 (NRF1) and mitochondrial transcription factor A (TFAM). Importantly, salicylate treatment significantly increased the number of mDNA, citrate synthase activity, expression of respiratory chain complex I, and mitochondrial mass, which were suppressed by the specific AMPK inhibitor Compound C. Indeed, salicylate treatment induced the phosphorylation of AMPK, which was involved in the induction of PGC-1α, NRF1, and TFAM. Importantly, inhibition of PGC-1α expression using PGC-1α small RNA interference abolished the effects of salicylate on mitochondrial biogenesis. These results suggest that salicylate has a potential therapeutic capacity against mitochondrial dysfunction in diabetes. - Highlights: • First time to show that salicylate promotes the expressions of PGC-1α, NRF1, TFAM. • First time to show that salicylate stimulates mitochondrial biogenesis. • AMPK mediates the effect of salicylate on PGC-1α expression. • Suggesting the roles of salicylate in mitochondrial dysfunction related disease.
ISSN 0006291X
Educational Use Research
Learning Resource Type Article
Publisher Date 2017-09-16
Publisher Place United States
Journal Biochemical and Biophysical Research Communications
Volume Number 491
Issue Number 2


Open content in new tab

   Open content in new tab